PapersFlow Research Brief
Electrolyte and hormonal disorders
Research Guide
What is Electrolyte and hormonal disorders?
Electrolyte and hormonal disorders refer to a cluster of medical conditions primarily involving hyponatremia, characterized by low sodium levels in the blood, often linked to heart failure, elderly patients, osteoporosis, and inappropriate antidiuresis, with vasopressin and copeptin serving as key biomarkers and neurological complications as frequent outcomes.
This field encompasses 63,396 published works on the diagnosis, evaluation, and treatment of hyponatremia and associated disorders. Research highlights connections to heart failure, as shown in trials like \"Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure\" (2014) and \"Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms\" (2010). Studies also address biomarkers such as vasopressin, copeptin, and aquaporin-4 pathways, alongside guidelines for related metabolic management.
Topic Hierarchy
Research Sub-Topics
Hyponatremia Diagnosis and Evaluation
This sub-topic covers diagnostic algorithms distinguishing euvolemic, hypovolemic, and hypervolemic hyponatremia using osmolality, urine studies, and clinical assessment. Researchers validate biomarkers like fractional urea excretion.
Hyponatremia Treatment Strategies
This sub-topic examines vasopressin antagonists, hypertonic saline, and fluid restriction protocols for acute and chronic hyponatremia. Researchers compare outcomes in randomized trials for correction rates and complications.
Hyponatremia in Heart Failure
This sub-topic investigates hyponatremia prevalence, prognostic implications, and management in acute decompensated heart failure with neurohormonal activation. Researchers study tolvaptan and ultrafiltration adjuncts.
Vasopressin and Copeptin in Hyponatremia
This sub-topic profiles arginine vasopressin dysregulation and copeptin as surrogate markers in SIADH, reset osmostat, and polydipsia. Researchers develop diagnostic cutoffs via immunoassay studies.
Neurological Complications of Hyponatremia
This sub-topic details brain edema, seizures, and osmotic demyelination syndrome risks with correction rapidity in severe hyponatremia. Researchers model cerebral adaptation and neuroprotective strategies.
Why It Matters
Electrolyte and hormonal disorders impact patient outcomes in heart failure management, where John J.V. McMurray et al. (2014) demonstrated in \"Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure\" that LCZ696 reduced risks of death and hospitalization compared to enalapril in the PARADIGM-HF trial (ClinicalTrials.gov NCT01035255). Faïez Zannad et al. (2010) showed in \"Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms\" that eplerenone lowered death and hospitalization risks versus placebo in systolic heart failure patients (ClinicalTrials.gov NCT00232180). These findings guide treatment in clinical settings, particularly for elderly patients prone to hyponatremia-related complications like neurological issues and osteoporosis, as explored in the field's focus on vasopressin and copeptin biomarkers.
Reading Guide
Where to Start
\"Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure\" by John J.V. McMurray et al. (2014), as it provides a clinical trial foundation linking heart failure treatments to electrolyte management outcomes with clear results on death and hospitalization risks.
Key Papers Explained
John J.V. McMurray et al.'s \"Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure\" (2014) establishes LCZ696's superiority over enalapril in heart failure, building on Faïez Zannad et al.'s \"Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms\" (2010), which showed eplerenone's benefits versus placebo. Jeffrey J. Iliff et al.'s \"A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β\" (2012) connects to Annabel M. Ruiter et al.'s \"Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient\" (2017) by detailing aquaporin-4 pathways relevant to neurological hyponatremia effects. Arduino A. Mangoni and Stephen H. Jackson's \"Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications\" (2003) contextualizes age impacts across these.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research derives from established works like heart failure trials and aquaporin-4 studies, with no recent preprints or news available; frontiers involve integrating biomarkers like copeptin with treatments for elderly hyponatremia patients and neurological risks.
Papers at a Glance
Frequently Asked Questions
What is the primary focus of research in electrolyte and hormonal disorders?
Research centers on diagnosis, evaluation, and treatment of hyponatremia, especially its links to heart failure, elderly patients, osteoporosis, and inappropriate antidiuresis. Vasopressin and copeptin function as key biomarkers, while neurological complications are commonly studied. The field includes 63,396 works addressing these aspects.
How does heart failure relate to hyponatremia in this field?
Hyponatremia associates closely with heart failure, as evidenced by trials testing interventions like LCZ696 and eplerenone. John J.V. McMurray et al. (2014) in \"Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure\" found LCZ696 superior to enalapril in reducing death and hospitalization risks. Faïez Zannad et al. (2010) in \"Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms\" reported eplerenone reduced risks versus placebo.
What role does aquaporin-4 play in electrolyte disorders?
Aquaporin-4 facilitates water transport in paravascular pathways for CSF flow and solute clearance through brain parenchyma. Annabel M. Ruiter et al. (2017) described anti-aquaporin 4-positive neuromyelitis optica presenting with autonomic dysregulation, cognitive impairment, and psychosis symptoms. Jeffrey J. Iliff et al. (2012) in \"A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β\" detailed its mediation by astrocytic endfeet.
What are common biomarkers for hyponatremia?
Vasopressin and copeptin serve as primary biomarkers in hyponatremia research. The field description emphasizes their role in diagnosis and association with inappropriate antidiuresis. Neurological complications often accompany these biomarker elevations.
How do age-related changes affect electrolyte and hormonal disorders?
Advancing age impairs regulatory processes, reducing homeostasis under stress and altering pharmacokinetics and pharmacodynamics. Arduino A. Mangoni and Stephen H. Jackson (2003) in \"Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications\" note this impacts electrolyte balance in elderly patients. Such changes heighten hyponatremia risks in this population.
What guidelines exist for related metabolic management?
Guidelines cover bone metabolism in chronic kidney disease, parenteral nutrition in intensive care, and nutrition support in critically ill adults. Shaul G. Massry et al. (2003) provide \"K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.\" Pierre Singer et al. (2009) offer \"ESPEN Guidelines on Parenteral Nutrition: Intensive care,\" and Stephen A. McClave et al. (2009) detail \"Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient.\"
Open Research Questions
- ? How can copeptin levels precisely predict hyponatremia risk in elderly heart failure patients?
- ? What mechanisms link aquaporin-4 dysfunction to neurological complications in hyponatremia?
- ? Which vasopressin antagonists best treat inappropriate antidiuresis without osteoporosis exacerbation?
- ? How do hormonal interactions in systolic heart failure influence electrolyte homeostasis?
- ? What paravascular pathways optimize CSF clearance of solutes in hyponatremic brain edema?
Recent Trends
The field maintains 63,396 works with no specified 5-year growth rate; no recent preprints or news from the last 12 months indicate steady focus on core topics like hyponatremia in heart failure from papers such as \"Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure\" (2014, 6582 citations) and persistent interest in vasopressin, copeptin, and aquaporin-4 without new shifts.
Research Electrolyte and hormonal disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Electrolyte and hormonal disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers